#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14118	16S	1529	1529	99.93	16S.l15.c17.ctg.2	2200	763.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1710	1710	T	907	T,G	902,5	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14118	16S	1529	1529	99.93	16S.l15.c17.ctg.2	2200	763.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1444	1444	C	887	C,A	886,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14118	16S	1529	1529	99.93	16S.l15.c17.ctg.2	2200	763.5	0	HET	.	.	.	C326T	.	326	326	C	586	586	C	910	C,T	683,227	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22958	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4115	695.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1962	1962	A	966	A	966	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22958	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4115	695.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2596	2596	C	757	C,T,G	754,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22958	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4115	695.8	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3222	3222	T	713	T,G	711,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22958	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4115	695.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2670	2670	A	699	A,G,C	697,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1578	folP	852	852	93.78	folP.l15.c4.ctg.1	2042	96.3	0	.	p	.	0	G5V	NONSYN	13	15	GGT	573	575	GTT	131;132;132	G;T,A;T	130;130,1;131	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1578	folP	852	852	93.78	folP.l15.c4.ctg.1	2042	96.3	0	.	p	.	0	E12K	NONSYN	34	36	GAA	594	596	AAA	143;145;142	A;A,G;A	143;144,1;142	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1578	folP	852	852	93.78	folP.l15.c4.ctg.1	2042	96.3	0	.	p	.	0	F31L	NONSYN	91	93	TTT	651	653	TTG	171;173;172	T;T;G,T	171;173;171,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1578	folP	852	852	93.78	folP.l15.c4.ctg.1	2042	96.3	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	684	686	CAA	193;193;193	C;A,C;A	193;192,1;193	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1578	folP	852	852	93.78	folP.l15.c4.ctg.1	2042	96.3	0	.	p	.	0	S75P	NONSYN	223	225	TCC	783	785	CCT	165;166;164	C;C,A;T	165;165,1;164	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1578	folP	852	852	93.78	folP.l15.c4.ctg.1	2042	96.3	0	.	p	.	0	V87A	NONSYN	259	261	GTA	819	821	GCA	139;140;142	G;C;A,C	139;140;141,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1578	folP	852	852	93.78	folP.l15.c4.ctg.1	2042	96.3	0	.	p	.	0	V130L	NONSYN	388	390	GTC	948	950	CTC	189;193;192	C,G;T,G;C,G	188,1;192,1;191,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1578	folP	852	852	93.78	folP.l15.c4.ctg.1	2042	96.3	0	.	p	.	0	R135C	NONSYN	403	405	CGC	963	965	TGT	201;201;202	T,C,G;G;T,C	198,1,2;201;201,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1578	folP	852	852	93.78	folP.l15.c4.ctg.1	2042	96.3	0	.	p	.	0	T137A	NONSYN	409	411	ACG	969	971	GCG	208;210;213	G;C;G	208;210;213	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1578	folP	852	852	93.78	folP.l15.c4.ctg.1	2042	96.3	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1011	1013	AAG	232;234;235	A;A,C;G,A,T	232;232,1;233,1,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1578	folP	852	852	93.78	folP.l15.c4.ctg.1	2042	96.3	0	.	p	.	0	T152N	NONSYN	454	456	ACC	1014	1016	AAT	235;238;235	A;A,C;T,C	235;235,3;234,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1578	folP	852	852	93.78	folP.l15.c4.ctg.1	2042	96.3	0	.	p	.	0	F218L	NONSYN	652	654	TTT	1212	1214	TTG	118;114;112	T;T;G	118;114;112	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1578	folP	852	852	93.78	folP.l15.c4.ctg.1	2042	96.3	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1242	1244	AGC	107;107;106	A;G;C	107;107;106	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1578	folP	852	852	93.78	folP.l15.c4.ctg.1	2042	96.3	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1311	1313	CTG	115;112;110	C;T;G	115;112;110	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1578	folP	852	852	93.78	folP.l15.c4.ctg.1	2042	96.3	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1317	1319	TCC	110;111;111	T;C;C	110;111;111	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1578	folP	852	852	93.78	folP.l15.c4.ctg.1	2042	96.3	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1332	1334	GTG	123;123;122	G;T;G	123;123;122	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1578	folP	852	852	93.78	folP.l15.c4.ctg.1	2042	96.3	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1383	1385	GCG	157;157;155	G;C;G	157;157;155	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5050	gyrA	2751	2751	100.0	gyrA.l15.c30.ctg.1	4027	156.5	1	SNP	p	S91F	0	.	.	271	273	TCC	932	934	TCC	162;161;162	T;C;C,A	162;161;161,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5050	gyrA	2751	2751	100.0	gyrA.l15.c30.ctg.1	4027	156.5	1	SNP	p	D95G	0	.	.	283	285	GAC	944	946	GAC	172;172;170	G,C;A;C	171,1;172;170	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5050	gyrA	2751	2751	100.0	gyrA.l15.c30.ctg.1	4027	156.5	1	SNP	p	D95N	0	.	.	283	285	GAC	944	946	GAC	172;172;170	G,C;A;C	171,1;172;170	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	531	1912	mtrR	633	633	99.68	mtrR.l6.c4.ctg.1	1732	137.4	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	959	959	T	217	T	217	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1090	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1543	88.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4574	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3517	162.1	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1735	1737	ATC	227;228;229	A,T;T,G;C,A	225,2;227,1;228,1	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4574	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3517	162.1	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1888	1890	GCA	218;219;220	G;C;A	218;219;220	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4574	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3517	162.1	1	SNP	p	D86N	0	.	.	256	258	GAC	841	843	GAC	210;210;207	G,T;A,C;C	209,1;209,1;207	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4574	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3517	162.1	1	SNP	p	S87I	0	.	.	259	261	AGT	844	846	AGT	206;206;210	A;G;T,A	206;206;209,1	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4574	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3517	162.1	1	SNP	p	S87R	0	.	.	259	261	AGT	844	846	AGT	206;206;210	A;G;T,A	206;206;209,1	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4574	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3517	162.1	1	SNP	p	S87W	0	.	.	259	261	AGT	844	846	AGT	206;206;210	A;G;T,A	206;206;209,1	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4574	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3517	162.1	1	SNP	p	S88P	0	.	.	262	264	TCC	847	849	TCC	211;210;213	T;C,A;C	211;209,1;213	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3936	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3177	154.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1792	1794	GGC	224;223;221	G;G,T;C	224;222,1;221	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	3826	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2985	159.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1569	1571	GCA	215;216;220	G;C,T;A	215;215,1;220	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3826	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2985	159.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1572	1574	ATC	219;219;218	A,C;T;C,A	218,1;219;215,2	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3826	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2985	159.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1584	1586	GTG	218;218;218	G;T,G;G,T	218;217,1;217,1	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3826	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2985	159.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1584	1586	GTG	218;218;218	G;T,G;G,T	218;217,1;217,1	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3826	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2985	159.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2088	2090	ACC	200;199;198	A;C;C	200;199;198	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3826	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2985	159.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2142	2144	GCG	183;183;184	G;C,G;G	183;181,2;184	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3826	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2985	159.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2142	2144	GCG	183;183;184	G;C,G;G	183;181,2;184	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3826	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2985	159.9	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2265	2267	GGT	229;227;227	G;G,C,A;T,C	229;225,1,1;226,1	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3826	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2985	159.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2274	2276	GGC	232;234;234	G,A;G;C	231,1;234;234	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3826	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2985	159.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2292	2294	CCG	227;228;225	C,G;C,T;G,T	226,1;227,1;223,1	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5240	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3602	181.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2194	porA	1146	1146	99.65	porA.l6.c17.ctg.1	2327	117.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	869	869	C	172	C	172	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	560	288	porB1a	984	156	92.95	porB1a.l15.c4.ctg.2	156	49.7	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	22;24;26	T,G;T;A	21,1;24;26	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	560	288	porB1a	984	156	92.95	porB1a.l15.c4.ctg.2	156	49.7	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	62;62;62	C;A;T	62;62;62	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	560	288	porB1a	984	156	92.95	porB1a.l15.c4.ctg.2	156	49.7	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	62;62;62	A;G;T	62;62;62	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	560	288	porB1a	984	156	92.95	porB1a.l15.c4.ctg.2	156	49.7	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	62;62;62	T;A;C	62;62;62	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2896	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	2057	175.4	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1190	1190	T	233	T	233	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2896	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	2057	175.4	1	SNP	p	G120K	0	.	.	358	360	GGT	917	919	GGT	228;228;235	G;G;T	228;228;235	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2896	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	2057	175.4	1	SNP	p	A121N	0	.	.	361	363	GCC	920	922	GCC	236;237;240	G;C,T;C	236;236,1;240	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2896	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	2057	175.4	1	SNP	p	A121D	0	.	.	361	363	GCC	920	922	GCC	236;237;240	G;C,T;C	236;236,1;240	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9628	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5260	228.0	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2200	2202	CAT	247;247;245	C,A;A,C;T	246,1;246,1;245	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1402	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1492	116.7	1	SNP	p	V57M	1	.	.	169	171	ATG	713	715	ATG	245;242;241	A;T;G	245;242;241	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
